Fatania Kavi, Vithayathil Mathew, Newbold Peter, Yoong Wai
4th Year Medical Students, UCL School of Medicine, Gower Street, London, UK.
Department of Obstetrics and Gynaecology, North Middlesex University Hospital, London, UK.
Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:111-4. doi: 10.1016/j.ejogrb.2013.12.003. Epub 2013 Dec 12.
To compare surgical outcomes in women with enlarged uteri >12 weeks' size who underwent vaginal hysterectomy compared to abdominal hysterectomy for non-prolapse indications.
Retrospective cohort study performed between 2007 and 2012 in a North London teaching hospital. The study group comprised 39 women who had vaginal hysterectomy (VH) with uteri >12 weeks size (200g) for non-prolapse indications. The next successive total abdominal hysterectomy (TAH) following the index case for similar indications (and with similar uterine weights) served as control (n=33). The groups were compared for pre- and post-operative demographic data, and main outcome measures were estimated blood loss, operation time, length of stay and complications.
Both VH and TAH groups had statistically similar pre-operative mean haemoglobin levels, age, body mass index, previous abdominal surgery, and American Society of Anesthesiologists (ASA) grade. Mean uterine weight (403.1±239.5 vs 460.5±236.2g) was comparable in both groups (both p>0.05). The mean duration of the procedure was similar (123.5±45.8 vs 119.8±44.9min, p=0.580) but women who had TAH lost 117ml more of blood (525.7±427.6 vs 408.2±411.8ml, p=0.039). Although overall complication rates were comparable between the groups (30.8% vs 36.4%, p=0.627), the mean post-operative stay was 55% shorter following VH (40.7±29.4 vs 90.7±46.2h, p<0.0001).
In women with non-prolapsed uteri >12 weeks' size, VH is a safe and cost effective option. The vaginal route is associated with significantly lower estimated blood loss and 55% shorter post-operative stay, with no increase in complication rates.
比较子宫增大超过12周大小的女性因非脱垂指征接受阴道子宫切除术与腹式子宫切除术的手术效果。
2007年至2012年在伦敦北部一家教学医院进行的回顾性队列研究。研究组包括39名因非脱垂指征接受子宫增大超过12周大小(200克)的阴道子宫切除术(VH)的女性。为类似指征(且子宫重量相似)在索引病例之后连续进行的下一例全腹式子宫切除术(TAH)作为对照(n = 33)。比较两组术前和术后的人口统计学数据,主要结局指标为估计失血量、手术时间、住院时间和并发症。
VH组和TAH组术前平均血红蛋白水平、年龄、体重指数、既往腹部手术史以及美国麻醉医师协会(ASA)分级在统计学上相似。两组平均子宫重量相当(403.1±239.5克对460.5±236.2克)(均p>0.05)。手术平均持续时间相似(123.5±45.8分钟对119.8±44.9分钟,p = 0.580),但接受TAH的女性失血多117毫升(525.7±427.6毫升对408.2±411.8毫升,p = 0.039)。尽管两组总体并发症发生率相当(30.8%对36.4%,p = 0.627),但VH术后平均住院时间短55%(40.7±29.4小时对90.7±46.2小时,p<0.0001)。
对于子宫增大超过12周大小的非脱垂女性,VH是一种安全且具有成本效益的选择。经阴道途径估计失血量显著更低,术后住院时间短55%,且并发症发生率未增加。